TB-500 Fragment (Ac-SDKP)
Also known as: Ac-SDKP, TB4 Fragment, N-acetyl-seryl-aspartyl-lysyl-proline
How It Works
Tetrapeptide fragment of Thymosin Beta-4 with potent anti-fibrotic and anti-inflammatory properties. Inhibits TGF-beta signaling, reduces fibrosis, and promotes angiogenesis without full TB-500 immune effects.
What It's Used For
Administration
Safety & Side Effects
Possible Side Effects
- ⚠Injection site reactions
- ⚠Mild headache
Contraindications
- ✘Active cancer
- ✘Pregnancy
Research Summary
Endogenous tetrapeptide released by ACE2. Studies show potent anti-fibrotic effects in cardiac, renal, and pulmonary fibrosis models. Under investigation as standalone anti-fibrotic therapeutic.
References
- Sharma U et al. Peptides. 2016
- Rasoul S et al. PLoS One. 2012
Legal & Availability
Research chemical
Dosing Protocol
Stacks Well With
BPC-157
Injury repair, Gut healing
TB-500
Tissue repair, Wound healing
GHK-Cu
Skin rejuvenation, Wound healing
Full stacking protocols and cycling schedules available with Pro subscription.
Is TB-500 Fragment (Ac-SDKP) Right for You?
Our AI analyzes your symptoms, labs, and medical history to determine if this peptide fits your protocol — and at what dose.
Is TB-500 Fragment (Ac-SDKP) right for you?
Get a free personalized analysis based on your symptoms and goals — delivered to your inbox.
This information is for educational purposes only and is not medical advice. Do not use any peptide without consulting a qualified healthcare provider. BioRoot AI is a clinical decision support tool — not a medical provider.